<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39402509</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>15</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2466</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>14</Day></PubDate></JournalIssue><Title>BMC pulmonary medicine</Title><ISOAbbreviation>BMC Pulm Med</ISOAbbreviation></Journal><ArticleTitle>The severity assessment and nucleic acid turning-negative-time prediction in COVID-19 patients with COPD using a fused deep learning model.</ArticleTitle><Pagination><StartPage>515</StartPage><MedlinePgn>515</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">515</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12890-024-03333-x</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Previous studies have shown that patients with pre-existing chronic obstructive pulmonary diseases (COPD) were more likely to be infected with coronavirus disease (COVID-19) and lead to more severe lung lesions. However, few studies have explored the severity and prognosis of COVID-19 patients with different phenotypes of COPD.</AbstractText><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">The aim of this study is to investigate the value of the deep learning and radiomics features for the severity evaluation and the nucleic acid turning-negative time prediction in COVID-19 patients with COPD including two phenotypes of chronic bronchitis predominant patients and emphysema predominant patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A total of 281 patients were retrospectively collected from Hohhot First Hospital between October 2022 and January 2023. They were divided to three groups: COVID-19 group of 95 patients, COVID-19 with emphysema group of 94 patients, COVID-19 with chronic bronchitis group of 92 patients. All patients underwent chest computed tomography (CT) scans and recorded clinical data. The U-net model was pretrained to segment the pulmonary involvement area on CT images and the severity of pneumonia were evaluated by the percentage of pulmonary involvement volume to lung volume. The 107 radiomics features were extracted by pyradiomics package. The Spearman method was employed to analyze the correlation of the data and visualize it through a heatmap. Then we establish a deep learning model (model 1) and a fusion model (model 2) combined deep learning with radiomics features to predict nucleic acid turning-negative time.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">COVID-19 patients with emphysema was lowest in the lymphocyte count compared to COVID-19 patients and COVID-19 companied with chronic bronchitis, and they have the most extensive range of pulmonary inflammation. The lymphocyte count was significantly correlated with pulmonary involvement and the time for nucleic acid turning negative (r=-0.145, P &lt; 0.05). Importantly, our results demonstrated that model 2 achieved an accuracy of 80.9% in predicting nucleic acid turning-negative time.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The pre-existing emphysema phenotype of COPD severely aggravated the pulmonary involvement of COVID-19 patients. Deep learning and radiomics features may provide more information to accurately predict the nucleic acid turning-negative time, which is expected to play an important role in clinical practice.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Liu</LastName><ForeName>Yanhui</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Medical Imaging Department, Hohhot First Hospital, Inner Mongolia, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhang</LastName><ForeName>Wenxiu</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Institute of Research and Clinical Innovations, Neusoft Medical Systems Co., Ltd, Shanghai, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Mengzhou</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Research and Clinical Innovations, Neusoft Medical Systems Co., Ltd, Beijing, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Xiaoyun</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Institute of Research and Clinical Innovations, Neusoft Medical Systems Co., Ltd, Shanghai, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Lu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Medical Imaging Department, Hohhot First Hospital, Inner Mongolia, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Jiaqi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Medical Imaging Department, Hohhot First Hospital, Inner Mongolia, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hou</LastName><ForeName>Yongquan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Respiratory and Critical Care Medicine Department, Hohhot First Hospital, Inner Mongolia, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Haina</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Medical Imaging Department, Hohhot First Hospital, Inner Mongolia, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Xiaoguang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Medical Imaging Department, Hohhot First Hospital, Inner Mongolia, P.R. China. 13347113579@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2023YFSH0015</GrantID><Agency>the Inner Mongolia Autonomous Region Science and Technology Plan Project</Agency><Country /></Grant><Grant><GrantID>2023YFSH0015</GrantID><Agency>the Inner Mongolia Autonomous Region Science and Technology Plan Project</Agency><Country /></Grant><Grant><GrantID>2023YFSH0015</GrantID><Agency>the Inner Mongolia Autonomous Region Science and Technology Plan Project</Agency><Country /></Grant><Grant><GrantID>2023YFSH0015</GrantID><Agency>the Inner Mongolia Autonomous Region Science and Technology Plan Project</Agency><Country /></Grant><Grant><GrantID>2023YFSH0015</GrantID><Agency>the Inner Mongolia Autonomous Region Science and Technology Plan Project</Agency><Country /></Grant><Grant><GrantID>2023YFSH0015</GrantID><Agency>the Inner Mongolia Autonomous Region Science and Technology Plan Project</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Pulm Med</MedlineTA><NlmUniqueID>100968563</NlmUniqueID><ISSNLinking>1471-2466</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029424" MajorTopicYN="Y">Pulmonary Disease, Chronic Obstructive</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077321" MajorTopicYN="Y">Deep Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="Y">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014057" MajorTopicYN="Y">Tomography, X-Ray Computed</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011656" MajorTopicYN="N">Pulmonary Emphysema</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 with COPD</Keyword><Keyword MajorTopicYN="N">Deep learning method</Keyword><Keyword MajorTopicYN="N">Nucleic acid turning-negative time</Keyword><Keyword MajorTopicYN="N">Pulmonary involvement</Keyword><Keyword MajorTopicYN="N">Radiomics features</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>15</Day><Hour>10</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>15</Day><Hour>0</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>23</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39402509</ArticleId><ArticleId IdType="pmc">PMC11476205</ArticleId><ArticleId IdType="doi">10.1186/s12890-024-03333-x</ArticleId><ArticleId IdType="pii">10.1186/s12890-024-03333-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Guo YR, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Military Med Res. 2020;7(1):11. 10.1186/s40779-020-00240-0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7068984</ArticleId><ArticleId IdType="pubmed">32169119</ArticleId></ArticleIdList></Reference><Reference><Citation>Mudatsir M, et al. Predictors of COVID-19 severity: a systematic review and meta-analysis. F1000Research. 2020;9:1107. 10.12688/f1000research.26186.2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7607482</ArticleId><ArticleId IdType="pubmed">33163160</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesan P. GOLD COPD report: 2023 update. The Lancet. Respir Med. 2023;11(1):18. 10.1016/S2213-2600(22)00494-5.</Citation><ArticleIdList><ArticleId IdType="pubmed">36462509</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez-Ramirez DC, Mackey D. Underlying respiratory diseases, specifically COPD, and smoking are associated with severe COVID-19 outcomes: a systematic review and meta-analysis. Respir Med. 2020;171:106096. 10.1016/j.rmed.2020.106096.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7391124</ArticleId><ArticleId IdType="pubmed">32763754</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu R, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet (London England). 2020;395(10224):565–74. 10.1016/S0140-6736(20)30251-8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159086</ArticleId><ArticleId IdType="pubmed">32007145</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansen MD, et al. Increased SARS-CoV-2 infection, protease, and inflammatory responses in Chronic Obstructive Pulmonary Disease Primary Bronchial epithelial cells defined with single-cell RNA sequencing. Am J Respir Crit Care Med. 2022;206(6):712–29. 10.1164/rccm.202108-1901OC.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9799113</ArticleId><ArticleId IdType="pubmed">35549656</ArticleId></ArticleIdList></Reference><Reference><Citation>Mallia P, et al. Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation. Am J Respir Crit Care Med. 2011;183(6):734–42. 10.1164/rccm.201006-0833OC.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3081284</ArticleId><ArticleId IdType="pubmed">20889904</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh D, Mathioudakis AG, Higham A. Chronic obstructive pulmonary disease and COVID-19: interrelationships. Curr Opin Pulm Med. 2022;28(2):76–83. 10.1097/MCP.0000000000000834.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8815646</ArticleId><ArticleId IdType="pubmed">34690257</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, et al. A bibliometric analysis of chronic obstructive pulmonary disease and COVID-19. Med (Baltim). 2023;102(10):e33240. 10.1097/MD.0000000000033240.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9997199</ArticleId><ArticleId IdType="pubmed">36897719</ArticleId></ArticleIdList></Reference><Reference><Citation>Zu ZY, et al. Coronavirus Disease 2019 (COVID-19): a perspective from China. Radiology. 2020;296(2):E15–25. 10.1148/radiol.2020200490.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7233368</ArticleId><ArticleId IdType="pubmed">32083985</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernheim A, et al. Chest CT findings in Coronavirus Disease-19 (COVID-19): relationship to duration of infection. Radiology. 2020;295(3):200463. 10.1148/radiol.2020200463.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7233369</ArticleId><ArticleId IdType="pubmed">32077789</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan F, et al. Time Course of Lung Changes at chest CT during recovery from Coronavirus Disease 2019 (COVID-19). Radiology. 2020;295(3):715–21. 10.1148/radiol.2020200370.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7233367</ArticleId><ArticleId IdType="pubmed">32053470</ArticleId></ArticleIdList></Reference><Reference><Citation>Francone M, et al. Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis. Eur Radiol. 2020;30(12):6808–17. 10.1007/s00330-020-07033-y.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7334627</ArticleId><ArticleId IdType="pubmed">32623505</ArticleId></ArticleIdList></Reference><Reference><Citation>Prakash J, et al. Computed tomography severity score as a predictor of disease severity and mortality in COVID-19 patients: a systematic review and meta-analysis. J Med Imaging Radiation Sci. 2023;54(2):364–75. 10.1016/j.jmir.2023.02.003.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9933858</ArticleId><ArticleId IdType="pubmed">36907753</ArticleId></ArticleIdList></Reference><Reference><Citation>Alqahtani JS, et al. Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: a Rapid systematic review and Meta-analysis. PLoS ONE. 2020;15(5):e0233147. 10.1371/journal.pone.0233147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7213702</ArticleId><ArticleId IdType="pubmed">32392262</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippi G, Henry BM. Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19). Respir Med. 2020;167:105941. 10.1016/j.rmed.2020.105941.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7154502</ArticleId><ArticleId IdType="pubmed">32421537</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2023. www.goldcopd.org.</Citation></Reference><Reference><Citation>Liu G, et al. LDH, CRP and ALB predict nucleic acid turn negative within 14 days in symptomatic patients with COVID-19. Scot Med J. 2021;66(3):108–14. 10.1177/0036933021994243.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8326898</ArticleId><ArticleId IdType="pubmed">33663273</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu K et al. Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Vaccination for Negative Conversion Time of Nucleic Acid in Nonsevere COVID-19 Patients Infected by SARS-CoV-2 Omicron Variant. International journal of clinical practice. 2023; 2023:9576855. 10.1155/2023/9576855</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10545465</ArticleId><ArticleId IdType="pubmed">37790860</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, et al. Clinical characteristics of hospitalized mild/moderate COVID-19 patients with a prolonged negative conversion time of SARS-CoV-2 nucleic acid detection. BMC Infect Dis. 2021;21(1):141. 10.1186/s12879-021-05851-z.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7856599</ArticleId><ArticleId IdType="pubmed">33535989</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T, Siegel E, Shen D. Deep learning and medical image analysis for COVID-19 diagnosis and prediction. Annu Rev Biomed Eng. 2022;24:179–201. 10.1146/annurev-bioeng-110220-012203.</Citation><ArticleIdList><ArticleId IdType="pubmed">35316609</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou T, et al. The ensemble deep learning model for novel COVID-19 on CT images. Appl Soft Comput. 2021;98:106885. 10.1016/j.asoc.2020.106885.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7647900</ArticleId><ArticleId IdType="pubmed">33192206</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie H, et al. Helping roles of Artificial Intelligence (AI) in the screening and evaluation of COVID-19 based on the CT images. J Inflamm Res. 2021;14:1165–72. 10.2147/JIR.S301866.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8009533</ArticleId><ArticleId IdType="pubmed">33814922</ArticleId></ArticleIdList></Reference><Reference><Citation>Farahat IS, et al. An AI-based novel system for predicting respiratory support in COVID-19 patients through CT imaging analysis. Sci Rep. 2024;14(1):851. 10.1038/s41598-023-51053-9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10774502</ArticleId><ArticleId IdType="pubmed">38191606</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali AM et al. COVID-19 pneumonia level detection using deep learning algorithm and transfer learning. Evol Intell 2022; Sep 10:1–12. 10.1007/s12065-022-00777-0</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9463680</ArticleId><ArticleId IdType="pubmed">36105664</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L et al. Vision Intelligence assisted lung function estimation based on Transformer encoder–Decoder Network with Invertible modeling. IEEE Trans Artif Intell, 5. 10.1109/TAI.2023.3348428</Citation></Reference><Reference><Citation>Dimitsaki S, et al. Benchmarking of Machine Learning classifiers on plasma proteomic for COVID-19 severity prediction through interpretable artificial intelligence. Artif Intell Med. 2023;137:102490. 10.1016/j.artmed.2023.102490.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9846931</ArticleId><ArticleId IdType="pubmed">36868685</ArticleId></ArticleIdList></Reference><Reference><Citation>Rezaeijo SM, et al. Screening of COVID-19 based on the extracted radiomics features from chest CT images. J X-Ray Sci Technol. 2021;29(2):229–43. 10.3233/XST-200831.</Citation><ArticleIdList><ArticleId IdType="pubmed">33612539</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao F, et al. Prediction of potential severe coronavirus disease 2019 patients based on CT radiomics: a retrospective study. Med Phys. 2022;49(9):5886–98. 10.1002/mp.15841.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9349830</ArticleId><ArticleId IdType="pubmed">35837868</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Z, et al. A novel CT-based radiomics in the distinction of severity of coronavirus disease 2019 (COVID-19) pneumonia. BMC Infect Dis. 2021;21(1):608. 10.1186/s12879-021-06331-0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8231742</ArticleId><ArticleId IdType="pubmed">34171991</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M, et al. An AI-based radiomics nomogram for disease prognosis in patients with COVID-19 pneumonia using initial CT images and clinical indicators. Int J Med Informatics. 2021;154:104545. 10.1016/j.ijmedinf.2021.104545.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8353975</ArticleId><ArticleId IdType="pubmed">34464848</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: interim guidance. https://www.who.int/docs/default-source/coronaviruse/clinical-management-of-novel-cov.pdf. Accessed January 30, 2020.</Citation></Reference><Reference><Citation>Büyükşirin M, et al. Does the benefit from pulmonary rehabilitation differ between phenotypes in chronic obstructive pulmonary disease? Eurasian J Pulmonol. 2021;23:32–40. 10.4103/ejop.ejop_26_20.</Citation></Reference><Reference><Citation>Ronneberger O, Fischer P, Brox T. U-net: Convolutional networks for biomedical image segmentation. International Conference on Medical Image Computing and Computer-Assisted Intervention.Springer, Cham, 2015. 10.1007/978-3-319-24574-4_28</Citation></Reference><Reference><Citation>van Griethuysen JJM, et al. Computational Radiomics System to Decode the Radiographic phenotype. Cancer Res. 2017;77(21):e104–7. 10.1158/0008-5472.CAN-17-0339.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5672828</ArticleId><ArticleId IdType="pubmed">29092951</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadoya N, et al. Homology-based radiomic features for prediction of the prognosis of lung cancer based on CT-based radiomics. Med Phys. 2020;47(5):2197–205. 10.1002/mp.14104.</Citation><ArticleIdList><ArticleId IdType="pubmed">32096876</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W, et al. Early diagnosis of High-Risk Chronic Obstructive Pulmonary Disease based on quantitative high-resolution computed tomography measurements. Int J Chron Obstruct Pulmon Dis. 2023;18:3099–114. 10.2147/COPD.S436803.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10757779</ArticleId><ArticleId IdType="pubmed">38162987</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, et al. Predictive values of neutrophil-to-lymphocyte ratio on disease severity and mortality in COVID-19 patients: a systematic review and meta-analysis. Crit Care (London England). 2020;24(1):647. 10.1186/s13054-020-03374-8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7667659</ArticleId><ArticleId IdType="pubmed">33198786</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkar S, Khanna P, Singh AK. The impact of Neutrophil-Lymphocyte count ratio in COVID-19: a systematic review and Meta-analysis. J Intensive Care Med. 2022;37(7):857–69. 10.1177/08850666211045626.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9160638</ArticleId><ArticleId IdType="pubmed">34672824</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan L, et al. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Signal Transduct Target Therapy. 2020;5(1):33. 10.1038/s41392-020-0148-4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7100419</ArticleId><ArticleId IdType="pubmed">32296069</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmoodpoor A, et al. Reduction and exhausted features of T lymphocytes under serological changes, and prognostic factors in COVID-19 progression. Mol Immunol. 2021;138:121–7. 10.1016/j.molimm.2021.06.001.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8343383</ArticleId><ArticleId IdType="pubmed">34392110</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Q, et al. Metabolic modeling of single bronchoalveolar macrophages reveals regulators of hyperinflammation in COVID-19. iScience. 2022;25(11):105319. 10.1016/j.isci.2022.105319.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9549388</ArticleId><ArticleId IdType="pubmed">36246577</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung JM, et al. ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19. Eur Respir J. 2020;55(5):2000688. 10.1183/13993003.00688-2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7144263</ArticleId><ArticleId IdType="pubmed">32269089</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci. 2020;63(3):364–74. 10.1007/s11427-020-1643-8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7088566</ArticleId><ArticleId IdType="pubmed">32048163</ArticleId></ArticleIdList></Reference><Reference><Citation>Celik E, et al. Quantitative determination of pulmonary emphysema in follow-up LD-CTs of patients with COVID-19 infection. PLoS ONE. 2022;17(2):e0263261. 10.1371/journal.pone.0263261.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8812925</ArticleId><ArticleId IdType="pubmed">35113939</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang N, et al. Clinical characteristics and chest CT imaging features of critically ill COVID-19 patients. Eur Radiol. 2020;30(11):6151–60. 10.1007/s00330-020-06955-x.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7260469</ArticleId><ArticleId IdType="pubmed">32474629</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q et al. Symptoms associated with nucleic acid turning-negative-time in COVID-19 patients? Acupuncture and herbal medicine. 2022; 2(3):207–9. 10.1097/HM9.0000000000000037</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9746246</ArticleId><ArticleId IdType="pubmed">37808353</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, et al. Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 Omicron. Nature. 2022;603(7901):493–6. 10.1038/s41586-022-04465-y.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8930761</ArticleId><ArticleId IdType="pubmed">35102312</ArticleId></ArticleIdList></Reference><Reference><Citation>Baden LR, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384(5):403–16. 10.1056/NEJMoa2035389.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7787219</ArticleId><ArticleId IdType="pubmed">33378609</ArticleId></ArticleIdList></Reference><Reference><Citation>Voysey M, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet (London England). 2021;397(10269):99–111. 10.1016/S0140-6736(20)32661-1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7723445</ArticleId><ArticleId IdType="pubmed">33306989</ArticleId></ArticleIdList></Reference><Reference><Citation>Zang X, et al. The value of early positive nucleic acid test and negative Conversion Time of SARS-CoV-2 RNA in the clinical outcome of COVID-19 patients. Front Med. 2022;9:826900. 10.3389/fmed.2022.826900.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9095906</ArticleId><ArticleId IdType="pubmed">35572983</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu G, et al. Structural and functional radiomics for lung cancer. Eur J Nucl Med Mol Imaging. 2021;48(12):3961–74. 10.1007/s00259-021-05242-1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8484174</ArticleId><ArticleId IdType="pubmed">33693966</ArticleId></ArticleIdList></Reference><Reference><Citation>Zorzi G, et al. Artificial intelligence for differentiating COVID-19 from other viral pneumonias on CT: comparative analysis of different models based on quantitative and radiomic approaches. Eur Radiol Experimental. 2023;7(1):3. 10.1186/s41747-022-00317-6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9870776</ArticleId><ArticleId IdType="pubmed">36690869</ArticleId></ArticleIdList></Reference><Reference><Citation>Avanzo M, et al. Machine and deep learning methods for radiomics. Med Phys. 2020;47(5):e185–202. 10.1002/mp.13678.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8965689</ArticleId><ArticleId IdType="pubmed">32418336</ArticleId></ArticleIdList></Reference><Reference><Citation>National Health Commission of the People’s Republic of China. Protocol for prevention and control of COVID-19 (9th Edition). Available online at: http://www.nhc.gov.cn/jkj/s3577/202206/de224e7784fe4007b7189c1f1c9d5e85.shtml</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8392946</ArticleId><ArticleId IdType="pubmed">34594648</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D, et al. False-negative results of real-time reverse-transcriptase polymerase chain reaction for severe Acute Respiratory Syndrome Coronavirus 2: role of deep-learning-based CT diagnosis and insights from two cases. Korean J Radiol. 2020;21(4):505–8. 10.3348/kjr.2020.0146.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7082661</ArticleId><ArticleId IdType="pubmed">32174053</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye J, et al. Predicting the negative conversion time of nonsevere COVID-19 patients using machine learning methods. J Med Virol. 2023;95(4):e28747. 10.1002/jmv.28747.</Citation><ArticleIdList><ArticleId IdType="pubmed">37185847</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>